drugset / Trial / NCT03876444

Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms

NCT03876444

Phase 2/3 Unknown 128 enrolled Suvasini Sharma
RandomizedParallel-groupOpen-labelTreatment

Summary

Infantile Spasms (IS) are classically refractory to the usual antiepileptic drugs and often pose a therapeutic challenge. Since, there is associated significant morbidity, much effort has been directed over the past years to evaluate the role of various anticonvulsants in the management of IS. High dose oral prednisolone has been shown to cause early cessation of spasms and resolution of hypsarrythmia on Electroencephalogram. Recently, role of intravenous methylprednislone pulse therapy has been explored as one of the therapeutic modality in IS, in order to avoid the development of side-effects associated with prolonged oral steroid therapy and maintain long-term efficacy.However, there are no studies comparing iv methylprednisolone pulse therapy with high dose oral prednisolone..

Timeline

Start
2019-04-01
Primary completion
2022-04-30
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 30 mg/kg Intravenous
Comparator Prednisolone Other / unclassified 4 mg/kg Oral

Indications